MedTrace Logo

Intensive Inpatient Trauma-Focused Cognitive Behavioral Therapy (II-TF-CBT) for Adolescents With PTSD Following Sexual Abuse

NCT07732335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-07-30

No results posted yet for this study

Summary

This study looks at a treatment program for children and teens who have post-traumatic stress disorder (PTSD) after sexual abuse. The program is called II-TF-CBT. It is a special version of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), a type of cognitive behavioral therapy that helps people process trauma. II-TF-CBT is used with patients who stay in the hospital during treatment.

Researchers want to know if II-TF-CBT helps young patients recover as well as, or better than, standard outpatient treatment. Outpatient treatment means patients visit the clinic but do not stay overnight.

The study compares two groups. One group of 42 patients received II-TF-CBT during a hospital stay. The other group of 33 patients received standard outpatient treatment. Patients needing inpatient care were placed on an admission waiting list and admitted as their turn came; the remaining patients continued outpatient follow-up. Group placement therefore happened naturally, without researcher intervention.

Doctors measured each patient's PTSD symptoms and related problems before treatment, after treatment, and at a follow-up visit. This will help show whether inpatient TF-CBT-based care can help children and teens recover from trauma.

Conditions

  • Child Sexual Abuse
  • Post-Traumatic Stress Disorder, PTSD

Interventions

BEHAVIORAL

II-TF-CBT

An inpatient adaptation of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) for children and adolescents with post-traumatic stress disorder following sexual abuse. The protocol follows the standard TF-CBT components (psychoeducation, relaxation, affect regulation, cognitive coping, trauma narrative, in vivo mastery, conjoint sessions, and safety enhancement), delivered during inpatient hospitalization.

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

  • Sevda Dabak, MD · Ankara City Hospital Bilkent

Eligibility

Min Age
11 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-05
Primary Completion
2026-06-10
Completion
2026-06-27

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07732335 on ClinicalTrials.gov